Peerbridge Health
- Company typePrivate
- Founded2013
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Peerbridge Health firmographics
Firmographics- Name
- Peerbridge Health
- Legal name
- Peerbridge Health
- Website
- https://peerbridgehealth.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Peerbridge Health industry classification
Industry- Product category
- Ambulatory Cardiac Diagnostic Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Cardiology Telemedicine Platforms (HLALAGAB)
Keywords
Where Peerbridge Health is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Peerbridge Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
Revenue model
- Cor ECG Wearable Device Sales: Sale of FDA-cleared ambulatory ECG wearable devices (Peerbridge Cor) to healthcare providers, clinics, and hospitals for cardiac monitoring and diagnostics
- AI-Enabled Diagnostics Software: Software-as-a-Medical Device (SaMD) platforms including CardioMIND and CardioQSync providing AI-driven cardiac and cardiopulmonary diagnostics from ECG data
- Clinical Trial Services: Revenue from clinical trial partnerships including COR-INSIGHT trial with up to 15,000 participants across hospitals, outpatient clinics, and medical research centers
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
Peerbridge Health product offering
Product offeringCore offering
Peerbridge Health sells the FDA-cleared Peerbridge Cor ambulatory ECG wearable system, the next-generation Cor MDx IoT ECG wearable, and proprietary AI Software-as-a-Medical Device (SaMD) platforms (CardioMIND and CardioQSync) that together deliver hospital-grade cardiac and cardiopulmonary diagnostics—30+ indications including heart failure, ejection fraction, and sleep apnea—from a single wireless patch. The platform is sold to hospitals, cardiology practices, primary care clinics, and health systems to enable continuous, remote, multi-lead ECG monitoring and earlier intervention.
Product overview
Peerbridge Health offers a unified cardiac diagnostics platform anchored by the Cor FDA-cleared ambulatory ECG wearable system and the next-generation Cor MDx IoT device. The platform is enhanced by proprietary AI SaMD solutions (CardioMIND for ECG+ analytics and CardioQSync for cardiopulmonary/hemodynamic extraction) designed to deliver 30+ cardiac and cardiopulmonary indications from a single wearable device. The architecture combines high-fidelity multi-lead ECG signal capture with AI-driven diagnostic capabilities for early disease detection, hemodynamic monitoring, and comprehensive cardiac assessment across clinic and home settings.
Differentiator
Problem solved
Functional benefit
Brands
- Cor: FDA-cleared ambulatory ECG system - patented multi-lead, 2-channel wireless AECG patch with Einthoven Triangle design capturing 31 cardiac rhythms
- Cor MDx
- CardioMIND
- CardioQSync
Products and services
- Peerbridge Cor FDA-cleared ambulatory ECG wearable system that pairs a comfortable multi-lead, 2-channel wireless patch with a clinic-friendly platform, capturing 31 cardiac rhythms with high-fidelity signal quality and clear P-wave/QRS morphology. Designed for hospitals, cardiology practices, primary care clinics, urgent care settings, and pharmacy clinics for routine screening, continuous monitoring, and earlier intervention.
- Cor MDx Next-generation IoT ECG wearable from Peerbridge Health with best-in-class signal fidelity and real-time multi-lead streaming over BLE and LTE, designed as a seamless, cost-effective solution spanning 14-day Holter monitoring, mobile cardiac telemetry, hemodynamic assessment, and acute care telemetry. Built for continuous cardiac monitoring across clinic, hospital, and at-home environments; FDA 510(k) submitted.
- CardioMIND Proprietary AI Software-as-a-Medical Device (SaMD) platform from Peerbridge Health providing an ECG+ analytical pipeline for cardiovascular indications and sleep disorder diagnosis, including ejection fraction and AHI-based sleep apnea determination, from continuous ECG captured by the Cor and Cor MDx wearables.
- CardioQSync Proprietary AI Software-as-a-Medical Device (SaMD) platform from Peerbridge Health using a quantum-resonance based approach to extract cardiopulmonary and hemodynamic indications—including cardiac output and stroke volume—from respiratory ECG signals captured by the Cor and Cor MDx wearables.
Quantifiable outcome
- 95.7% success rate in early detection of heart failure
- +5 more outcomes
Companies that use Peerbridge Health
Customer profileNamed customers11 records
Segments5 records
Ideal customer profiles4 records
Peerbridge Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability7 records
Feature8 records
Peerbridge Health partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered flagship and core.
- HeartX Program (HealthTech Arkansas and MedAxiom)flagshipHeartX cardiovascular accelerator program partners including HealthTech Arkansas and MedAxiom collaborate with Peerbridge for COR-INSIGHT trial expansion. Leading cardiologists at HCA, Mercy Health, and Louisiana Cardiology Associates participate, with focus on delivering improved outcomes to rural patients across the U.S.
- HCA HealthcarecoreHCA Healthcare participates as HeartX program partner providing clinical trial sites for COR-INSIGHT trial with up to 15,000 participants, focusing on expanding access to rural patients.
- Mercy HealthcoreMercy Health participates as HeartX program partner providing clinical trial sites for COR-INSIGHT trial expansion.
- Louisiana Cardiology AssociatescoreLouisiana Cardiology Associates participates as HeartX program partner providing clinical trial sites and cardiologist expertise for COR-INSIGHT trial.
- AT&TcoreAT&T provides the IoT backbone for Cor MDx wearable device, enabling real-time data transmission, remote study reconfiguration, and seamless management over LTE. This partnership supports Peerbridge's mission to deliver continuous cardiac monitoring for patients everywhere through secure, intelligent wireless connectivity.
- Northwell HealthcoreNorthwell Health serves as clinical trial partner for EF-ACT pivotal trial with approximately 1,000 patients. Nicolas Skipitaris, MD serves as Chairman of Cardiovascular Medicine at Northwell Health's Westchester Hospitals and provides clinical endorsement.
- Hackensack Meridian HealthcoreHackensack Meridian Health participates as clinical trial partner for EF-ACT pivotal trial evaluating ejection fraction severity from AI-enabled remote ECG wearable.
- Mount Sinai Health SystemcoreMount Sinai Health System participates as clinical trial partner for EF-ACT pivotal trial evaluating ejection fraction severity from AI-enabled remote ECG wearable.
- LeBauer-Brodie Center for Cardiovascular Research at Cone HealthcoreLeBauer-Brodie Center for Cardiovascular Research at Cone Health participates as clinical trial partner for EF-ACT pivotal trial.
- Orange County Heart InstitutecoreOrange County Heart Institute in California participates as clinical trial partner for EF-ACT pivotal trial evaluating ejection fraction severity.
Scale indicators10 records
Recent moves6 records
Expansion highlights7 records
Peerbridge Health competitors and assessment
Company assessmentDirect peers
- iRhythm Technologies: iRhythm's Zio is the dominant FDA-cleared ambulatory ECG patch service for cardiac arrhythmia detection, directly competing with Peerbridge Cor in cardiology practices and primary care screening workflows.
- AliveCor: AliveCor's KardiaMobile and KardiaStation provide AI-enabled single- and six-lead ECG capture for clinicians and consumers, competing head-to-head with Peerbridge's multi-lead AI ECG diagnostics in primary care and remote monitoring.
- Cardiac Insight: Cardiac Insight develops wearable ECG-based diagnostic tools with proprietary AI algorithms for arrhythmia and cardiac condition detection, a closely comparable emerging peer in ambulatory cardiac AI.
- Eko Health: Eko combines digital stethoscopes with AI-enabled ECG and cardiac biomarker analysis, targeting similar primary care and cardiology point-of-care use cases as Peerbridge Cor.
Broad incumbents
- Hillrom / Baxter: Hillrom (acquired by Baxter) acquired Bardy Diagnostics, adding a cardiac patch monitor to its broader patient monitoring portfolio, competing across inpatient telemetry and ambulatory ECG channels.
- Philips (BioTel Heart): Philips BioTel Heart provides mobile cardiac telemetry and ambulatory ECG monitoring services to hospitals and cardiology practices, representing a larger, established competitor in continuous cardiac monitoring.
- Medtronic: Medtronic's insertable cardiac monitors (Reveal LINQ), diagnostic catheters, and remote monitoring services establish it as a broad incumbent in cardiac diagnostics adjacent to Peerbridge's heart failure and ejection fraction focus.
- Boston Scientific: Through its Preventice acquisition and broader cardiac diagnostics portfolio, Boston Scientific offers ambulatory ECG monitoring solutions that overlap with Peerbridge's hospital and cardiology channel.
- GE HealthCare: GE HealthCare offers hospital-grade ECG, cardiac telemetry, and patient monitoring infrastructure where Peerbridge Cor and Cor MDx compete for in-hospital and remote monitoring deployments.
Emerging players
- Apple (Apple Watch ECG): Apple Watch's FDA-cleared single-lead ECG feature competes at the consumer-driven entry point into cardiac screening, potentially feeding demand for clinician-grade confirmatory diagnostics like Peerbridge Cor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Peerbridge Health social profiles
Digital presencePeerbridge Health compliance and trust
Trust signalCompliance2 records
Peerbridge Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Peerbridge Health leadership team
Management profileNumber of profiles
Profiles9 records
Peerbridge Health funding detail
Funding detailFunding overview
Funding rounds6 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Peerbridge Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Peerbridge Health
What does Peerbridge Health do?
Peerbridge Health sells the FDA-cleared Peerbridge Cor ambulatory ECG wearable system, the next-generation Cor MDx IoT ECG wearable, and proprietary AI Software-as-a-Medical Device (SaMD) platforms (CardioMIND and CardioQSync) that together deliver hospital-grade cardiac and cardiopulmonary diagnostics—30+ indications including heart failure, ejection fraction, and sleep apnea—from a single wireless patch. The platform is sold to hospitals, cardiology practices, primary care clinics, and health systems to enable continuous, remote, multi-lead ECG monitoring and earlier intervention.
Is Peerbridge Health a public or private company?
Peerbridge Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Peerbridge Health founded?
Peerbridge Health was founded in 2013. It employs 11 to 50 people.
Where is Peerbridge Health based?
Peerbridge Health is headquartered in New York, United States, in the North America region.
How does Peerbridge Health make money?
Three revenue lines are on record. Cor ECG Wearable Device Sales are the primary driver. The others are AI-Enabled Diagnostics Software and clinical Trial Services.
Who are Peerbridge Health's main competitors?
Direct peers on record are iRhythm Technologies, AliveCor, Cardiac Insight and Eko Health. Broad incumbents are Hillrom / Baxter, Philips (BioTel Heart), Medtronic, Boston Scientific and GE HealthCare. Apple (Apple Watch ECG) is listed as an emerging player.
Does Peerbridge Health have an API?
No public API is recorded for Peerbridge Health.
What industry is Peerbridge Health in?
Peerbridge Health's product category is Ambulatory Cardiac Diagnostic Devices. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.